Ponazuril

Drugbox
IUPAC_name = 1-Methyl-3- [3-methyl-4- [4-(trifluoromethylsulfonyl)phenoxy] phenyl] -1,3,5-triazinane-2,4,6-trione

---

CAS_number = 69004-04-2
CAS_supplemental =
ATC_prefix =
ATC_suffix =
ATC_supplemental =
PubChem = 3050408
DrugBank =
chemical_formula =
C=18 | H=14 | F=3 | N=3 | O=6 | S=1
molecular_weight = 457.380 g/mol
bioavailability =
protein_bound =
metabolism =
elimination_half-life =
excretion =
pregnancy_AU =
pregnancy_US =
pregnancy_category=
legal_AU =
legal_CA =
legal_UK =
legal_US = Rx-only
legal_status = "Veterinary use only"
routes_of_administration = Oral

Ponazuril (INN), sold by the Bayer Corporation under the trade name Marquis, is a drug currently approved for the treatment of equine protozoal myeloencephalitis in horses, caused by "Sarcocystis neurona".